| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | AMP-binding | 3.83e-05 | 30 | 41 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 3.83e-05 | 30 | 41 | 3 | IPR000873 | |
| Domain | DMAP_binding | 4.68e-05 | 5 | 41 | 2 | PF06464 | |
| Domain | Protocadherin | 4.68e-05 | 5 | 41 | 2 | PF08374 | |
| Domain | Protocadherin | 4.68e-05 | 5 | 41 | 2 | IPR013585 | |
| Domain | DMAP_binding | 7.01e-05 | 6 | 41 | 2 | SM01137 | |
| Domain | DMAP1-bd | 7.01e-05 | 6 | 41 | 2 | IPR010506 | |
| Domain | AMP_BINDING | 1.71e-03 | 28 | 41 | 2 | PS00455 | |
| Domain | GPCR_Rhodpsn_7TM | 3.21e-03 | 670 | 41 | 6 | IPR017452 | |
| Domain | - | 3.31e-03 | 39 | 41 | 2 | 2.120.10.30 | |
| Domain | 7tm_1 | 3.38e-03 | 677 | 41 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 3.58e-03 | 685 | 41 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.74e-03 | 691 | 41 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.77e-03 | 692 | 41 | 6 | IPR000276 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.58e-03 | 46 | 41 | 2 | IPR011042 | |
| Domain | CUB | 5.18e-03 | 49 | 41 | 2 | PF00431 | |
| Domain | CUB | 5.39e-03 | 50 | 41 | 2 | SM00042 | |
| Domain | - | 5.82e-03 | 52 | 41 | 2 | 2.60.120.290 | |
| Domain | CUB | 6.04e-03 | 53 | 41 | 2 | PS01180 | |
| Domain | CUB_dom | 6.95e-03 | 57 | 41 | 2 | IPR000859 | |
| Domain | Cadherin_N | 8.96e-03 | 65 | 41 | 2 | IPR013164 | |
| Domain | Cadherin_2 | 8.96e-03 | 65 | 41 | 2 | PF08266 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23600975 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12137943 | ||
| Pubmed | Quantitative analysis of alternative transcripts of human PCDH11X/Y genes. | 1.36e-06 | 2 | 41 | 2 | 19859901 | |
| Pubmed | A comparative analysis of the pig, mouse, and human PCDHX genes. | 1.36e-06 | 2 | 41 | 2 | 15112107 | |
| Pubmed | Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala. | 1.36e-06 | 2 | 41 | 2 | 22592879 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 22744706 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 14727141 | ||
| Pubmed | Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. | 1.36e-06 | 2 | 41 | 2 | 11003707 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25687328 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21276771 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16874762 | ||
| Pubmed | PCDH11 is X/Y homologous in Homo sapiens but not in Gorilla gorilla and Pan troglodytes. | 1.36e-06 | 2 | 41 | 2 | 16825765 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 17236128 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 19125366 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21173574 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21129452 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29973096 | ||
| Pubmed | Case-control association analysis of rheumatoid arthritis with candidate genes using related cases. | 8.12e-06 | 4 | 41 | 2 | 18466531 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19438904 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 16135528 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 24647733 | ||
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 7.41e-05 | 11 | 41 | 2 | 15905963 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 14660691 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 1.22e-04 | 14 | 41 | 2 | 20847152 | |
| Pubmed | A genome-wide association study identifies two new risk loci for Graves' disease. | 1.61e-04 | 16 | 41 | 2 | 21841780 | |
| Pubmed | 1.64e-04 | 233 | 41 | 4 | 37704626 | ||
| Pubmed | Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes. | 1.82e-04 | 17 | 41 | 2 | 34879283 | |
| Pubmed | Genetically distinct subsets within ANCA-associated vasculitis. | 2.05e-04 | 18 | 41 | 2 | 22808956 | |
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 23920377 | ||
| Pubmed | Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. | 2.29e-04 | 19 | 41 | 2 | 20395239 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 3.09e-04 | 22 | 41 | 2 | 30446499 | |
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 20932654 | ||
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 4.00e-04 | 25 | 41 | 2 | 23563309 | |
| Pubmed | 4.37e-04 | 125 | 41 | 3 | 19019335 | ||
| Pubmed | 4.67e-04 | 27 | 41 | 2 | 23096701 | ||
| Pubmed | Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons. | 4.67e-04 | 27 | 41 | 2 | 24496616 | |
| Pubmed | Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. | 4.69e-04 | 128 | 41 | 3 | 18818748 | |
| Pubmed | Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. | 4.69e-04 | 128 | 41 | 3 | 19527514 | |
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 5.03e-04 | 28 | 41 | 2 | 31600191 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 5.26e-04 | 317 | 41 | 4 | 17620599 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 5.96e-04 | 139 | 41 | 3 | 25476789 | |
| Pubmed | 6.58e-04 | 32 | 41 | 2 | 38060382 | ||
| Pubmed | 7.87e-04 | 35 | 41 | 2 | 25977363 | ||
| Pubmed | 8.33e-04 | 36 | 41 | 2 | 35379950 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 35918150 | ||
| Pubmed | 9.65e-04 | 650 | 41 | 5 | 38777146 | ||
| Pubmed | Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients. | 9.77e-04 | 39 | 41 | 2 | 19760754 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.07e-03 | 170 | 41 | 3 | 16159877 | |
| Pubmed | 1.13e-03 | 42 | 41 | 2 | 29107558 | ||
| Cytoband | 9p22.1 | 7.03e-05 | 14 | 41 | 2 | 9p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p22 | 1.04e-03 | 53 | 41 | 2 | chr9p22 | |
| GeneFamily | Non-clustered protocadherins | 2.11e-04 | 12 | 33 | 2 | 21 | |
| GeneFamily | Olfactory receptors, family 4 | 1.66e-03 | 129 | 33 | 3 | 151 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3 | 2.12e-05 | 331 | 37 | 6 | GSM538329_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d tetramer CD4, Spleen, avg-1 | 2.76e-05 | 347 | 37 | 6 | GSM538322_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4 | 2.90e-05 | 350 | 37 | 6 | GSM538318_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 2.95e-05 | 351 | 37 | 6 | GSM538325_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#2_top-relative-expression-ranked_500 | 1.20e-04 | 55 | 37 | 3 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k2_500 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-07 | 177 | 41 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.22e-07 | 189 | 41 | 5 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-07 | 191 | 41 | 5 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-07 | 193 | 41 | 5 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-07 | 193 | 41 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-07 | 193 | 41 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-07 | 194 | 41 | 5 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-07 | 194 | 41 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.09e-06 | 200 | 41 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 8.55e-06 | 141 | 41 | 4 | 7cbe8abdd004430d58ce31e0b613894a4cf6726e | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.27e-05 | 156 | 41 | 4 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-05 | 170 | 41 | 4 | 49fc45d8a5c3ad89d1649fa46d7a285891379392 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 174 | 41 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 174 | 41 | 4 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 2.09e-05 | 177 | 41 | 4 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-05 | 177 | 41 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-05 | 179 | 41 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 180 | 41 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-05 | 181 | 41 | 4 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 181 | 41 | 4 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 182 | 41 | 4 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 41 | 4 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 2.59e-05 | 187 | 41 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.59e-05 | 187 | 41 | 4 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-05 | 189 | 41 | 4 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.76e-05 | 190 | 41 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.76e-05 | 190 | 41 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.76e-05 | 190 | 41 | 4 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 191 | 41 | 4 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 191 | 41 | 4 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.82e-05 | 191 | 41 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 191 | 41 | 4 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.82e-05 | 191 | 41 | 4 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-05 | 192 | 41 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 193 | 41 | 4 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-05 | 193 | 41 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-05 | 193 | 41 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-05 | 193 | 41 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 193 | 41 | 4 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.00e-05 | 194 | 41 | 4 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-05 | 194 | 41 | 4 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-05 | 194 | 41 | 4 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 195 | 41 | 4 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 196 | 41 | 4 | 26f626e4df364e458431a5eccae076d1bed94ed4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 196 | 41 | 4 | 7773735a570fa1c482654058245ddb364062e26d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 196 | 41 | 4 | 578afe58962a24874b99b0407a647b12e972344b | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-05 | 196 | 41 | 4 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-05 | 197 | 41 | 4 | d0962c94f4b07759b0c9dade75c39fd2deec2f21 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 3.31e-05 | 199 | 41 | 4 | 1acf522a5d296042fe9f1cb47c1a06fc22da75a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-05 | 199 | 41 | 4 | 33b69b7b1542cc826380cb4f2629c422b7f85c9a | |
| ToppCell | distal-Hematologic-Natural_Killer_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.31e-05 | 199 | 41 | 4 | cf9c5b2a7d2b53d06d2f8edd1b2d12b6719ebfef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-05 | 199 | 41 | 4 | 017d67582f80d90f20b3d02044fa2e32f3dff289 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-05 | 199 | 41 | 4 | 44ea9c41a20252fae403f993f6646c2f4073c23d | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | distal-Hematologic-CD8+_Memory/Effector_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-05 | 200 | 41 | 4 | afe449c36e33b1ff0828389d82e2f620977bc695 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | a1a4c5cbf4c009d4c09699a16e2d5b814a8751ca | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.92e-04 | 122 | 41 | 3 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-04 | 126 | 41 | 3 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-04 | 127 | 41 | 3 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-04 | 130 | 41 | 3 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 133 | 41 | 3 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-04 | 134 | 41 | 3 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.88e-04 | 140 | 41 | 3 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.94e-04 | 141 | 41 | 3 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.07e-04 | 143 | 41 | 3 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.39e-04 | 148 | 41 | 3 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | severe_influenza-Treg|World / disease group, cell group and cell class (v2) | 3.46e-04 | 149 | 41 | 3 | 2a3a00cdf604c8f3f3863df0ddb06938549bf86d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.46e-04 | 149 | 41 | 3 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-04 | 150 | 41 | 3 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 151 | 41 | 3 | 72c47ed207951e73ef6c72085b2a3f48a99be952 | |
| ToppCell | severe_COVID-19-Treg|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.60e-04 | 151 | 41 | 3 | bef8f31d5c4345a346fcf15db0fa36265ac304e7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.60e-04 | 151 | 41 | 3 | 2f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64 | |
| ToppCell | severe_influenza-Treg|severe_influenza / disease group, cell group and cell class (v2) | 3.81e-04 | 154 | 41 | 3 | 25f74dfb0f0e014a232bc5318928c478480b178d | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-04 | 155 | 41 | 3 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.11e-04 | 158 | 41 | 3 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.50e-04 | 163 | 41 | 3 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-04 | 163 | 41 | 3 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-04 | 163 | 41 | 3 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-04 | 163 | 41 | 3 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.66e-04 | 165 | 41 | 3 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-04 | 165 | 41 | 3 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.74e-04 | 166 | 41 | 3 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-04 | 166 | 41 | 3 | 62523e635784512b3261b672beaa7747cb9d114a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 4.74e-04 | 166 | 41 | 3 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.74e-04 | 166 | 41 | 3 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.83e-04 | 167 | 41 | 3 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 167 | 41 | 3 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.83e-04 | 167 | 41 | 3 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 167 | 41 | 3 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 167 | 41 | 3 | eff3723fe60755272eca237459165e436e919ece | |
| Disease | Graves Disease | 5.78e-05 | 9 | 38 | 2 | C0018213 | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 7.22e-05 | 10 | 38 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | late-onset myasthenia gravis | 2.44e-04 | 18 | 38 | 2 | EFO_1001490 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.96e-04 | 301 | 38 | 4 | DOID:684 (is_marker_for) | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 5.98e-04 | 28 | 38 | 2 | DOID:784 (biomarker_via_orthology) | |
| Disease | stimulant use measurement | 5.98e-04 | 28 | 38 | 2 | EFO_0600076 | |
| Disease | renal cell carcinoma (is_marker_for) | 6.02e-04 | 128 | 38 | 3 | DOID:4450 (is_marker_for) | |
| Disease | Takayasu arteritis | 9.17e-04 | 148 | 38 | 3 | EFO_1001857 | |
| Disease | hyperthyroidism | 9.35e-04 | 35 | 38 | 2 | EFO_0009189 | |
| Disease | response to radiation, prostate carcinoma, erectile dysfunction | 1.05e-03 | 37 | 38 | 2 | EFO_0001663, EFO_0004234, GO_0009314 | |
| Disease | Prostatic Neoplasms | 1.11e-03 | 616 | 38 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.11e-03 | 616 | 38 | 5 | C0376358 | |
| Disease | Graves' disease (is_implicated_in) | 1.16e-03 | 39 | 38 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.68e-03 | 47 | 38 | 2 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | monoclonal gammopathy | 2.14e-03 | 53 | 38 | 2 | EFO_0000203 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCMWHILICLAAYLG | 211 | Q5QJU3 | |
| LYIMCVPHSVWGCAN | 26 | Q86SQ4 | |
| SIYVCCIVWMLALGG | 171 | Q9UPC5 | |
| WLCGACVFVHRMAQF | 286 | P0C7M7 | |
| CCMAVVDTGEVYVWG | 216 | O95199 | |
| CGRTGVICAIDYTWM | 231 | Q9Y2R2 | |
| WIDCCEYPHIGRVGM | 3146 | Q9NZR2 | |
| TVPGLCQDYCLDMWH | 106 | Q96JK4 | |
| GALNCLSCVWSYHLM | 1631 | Q92824 | |
| LSCVWSYHLMGGICT | 1636 | Q92824 | |
| CCILVALSWMGGFIH | 141 | Q8NGD0 | |
| VLACWCGGFIHSIMQ | 146 | Q8NH05 | |
| MSWCLQCSQGVAYLH | 131 | O43318 | |
| LLVCVFGLAAHWMAC | 381 | O95259 | |
| CMPLHYGAFVSWGTC | 131 | Q8NGQ2 | |
| QECLIYGHSDACWMP | 1141 | Q9BZA7 | |
| HWCTNGHLMCAGCFI | 81 | Q6ZMK1 | |
| GVVLYCACWHNGMSE | 876 | O14786 | |
| AYCGGLWLAAVAVMV | 686 | Q9HCG7 | |
| GTYMGHTGAVWCVDA | 46 | Q13347 | |
| GLWADCVMATGLYHC | 51 | O75508 | |
| LGFVLWCLCSVYSGH | 1186 | Q9Y2E4 | |
| VCYRVVMQLCGLWGH | 821 | Q5VZ89 | |
| ILALGDYMGATCHAC | 121 | Q14240 | |
| LGFALWCLCSVYSGH | 1201 | Q14689 | |
| CALLMAASWVGGFIH | 141 | Q8NGN0 | |
| CLIYGHSDACWMPAS | 1136 | Q9BZA8 | |
| LYLWISACAMLLCHG | 11 | Q7Z5A9 | |
| LMYGCLGAVAWCHVT | 71 | Q8IW70 | |
| HCCALGWLSMVYEGV | 1171 | Q9HCM1 | |
| MAGCYWLPGSTVEHV | 101 | Q96ME1 | |
| CHYSGAVTSMCWNRG | 36 | Q96D42 | |
| MVAEWQCVGFCHGVL | 321 | Q9BVL4 | |
| PMNGHCHLWYAVLCG | 256 | Q96LZ7 | |
| GACGYIGTLVHNSCW | 1366 | Q9H5I5 | |
| VCMKHVDGTCSWYRG | 196 | Q99727 | |
| YSCMNVGVSLCVWAG | 41 | Q8TCU3 | |
| MIYGCISYWGLHCET | 496 | Q8IUH5 | |
| IQHVCLYEIGWCSMI | 351 | Q8N584 | |
| WYHCHTCKMVDGVGV | 1676 | Q5T4S7 | |
| WSYNCVLSCIAIGGM | 346 | Q15849 | |
| MGNACWELYCLEHGI | 16 | P68366 | |
| RHACAIMVGGWVCCF | 536 | P16473 |